Order Article Reprints

Pérez-Castrillón JL, Jódar-Gimeno E, Nociar J, Lojka M, Nikolov D, Cereto-Castro F, Novković S, Tarantino U, Mehsen-Cetre N, Arranz P, et al. A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients. 2025; 17(4):672. https://doi.org/10.3390/nu17040672

Pérez-Castrillón, Jose Luis, Esteban Jódar-Gimeno, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, and et al. 2025. "A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency" Nutrients 17, no. 4: 672. https://doi.org/10.3390/nu17040672

Pérez-Castrillón, J. L., Jódar-Gimeno, E., Nociar, J., Lojka, M., Nikolov, D., Cereto-Castro, F., Novković, S., Tarantino, U., Mehsen-Cetre, N., Arranz, P., Martínez Ostalé, C., García-Bea, A., & Gilaberte, I. (2025). A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients, 17(4), 672. https://doi.org/10.3390/nu17040672